In The News is a concise digest of health care news in Vermont and the nation. VMS is not responsible for the content of the articles.
VERMONT NEWS
VTDigger: Shumlin touts health exchange as best argument for Obamacare
Gov. Peter Shumlin said Tuesday that Vermont Health Connect is working as well as it possibly can and the majority of users are not experiencing problems. The governor used the status update on Vermont Health Connect to defend the federal Affordable Care Act that created it. He said it would be “a disaster” for Vermont if President-elect Donald Trump dismantled the law, as he promised during the campaign. More »
VPR: For Some Vermonters Suffering From Hepatitis C, Life-Saving Cure Is Out Of Reach
Health advocates are challenging a Vermont Medicaid policy that has restricted curative treatment for hepatitis C only to patients with advanced liver problems. And while state officials say they’re open to changing the policy, they say offering treatment to all low-income Vermonters could cost taxpayers as much as $25 million over two years. More »
NATIONAL NEWS
Washington Post: Getting rid of Obamacare may take longer than Trump plans
President-elect Donald Trump and congressional Republicans promised during the campaign to quickly repeal and replace President Obama’s signature health-care law if they controlled Washington. Now GOP lawmakers are predicting it could take years to fulfill that pledge. Republican leaders in the House and Senate on Tuesday began emphasizing that even if Congress moves quickly on a vote to repeal the Affordable Care Act, it will take time to ease people out of its programs and replace it with their long-promised alternative. More »
Modern Healthcare: CMS' star ratings for hospitals linked to social, economic factors
The CMS' hospital quality star ratings have been strongly criticized by industry stakeholders and Congress as unfairly tarnishing the reputations of hospitals in low-income communities. A new study reinforces the concerns, concluding that a hospital's rating is heavily influenced by its location's socio-economic conditions. More »
NY Times: FDA agrees to new trials for ecstasy as relief for PTSD patients
After three tours in Iraq and Afghanistan, C. J. Hardin wound up hiding from the world in a backwoods cabin in North Carolina. Divorced, alcoholic and at times suicidal, he had tried almost all the accepted treatments for post-traumatic stress disorder: psychotherapy, group therapy and nearly a dozen different medications. Then, in 2013, he joined a small drug trial testing whether PTSD could be treated with MDMA, the illegal party drug better known as Ecstasy. “It changed my life,” he said in a recent interview in the bright, airy living room of the suburban ranch house here, where he now lives while going to college and working as an airplane mechanic. More »
Washington Post: Daily mile’ craze in Britain hopes to tackle national obesity crisis
Torriano primary school in north London doesn’t have lush green grounds or an outdoor running track or a leafy campus quad. But on most days, its students do something that is being replicated in schools across the country: They put down their pencils, step into the great outdoors and run a mile. Every day, tens of thousands of school children across Britain — in addition to regular physical-education classes — run, jog or walk a mile under a voluntary scheme dubbed the “daily mile.” This running craze adopted by schools up and down the country comes amid an obesity crisis in Britain. More »
NY Times: Hallucinogen Eases Depression in Cancer Patients, Studies Find
On a summer morning in 2013, Octavian Mihai entered a softly lit room furnished with a small statue of Buddha, a box of tissues and a single red rose. From an earthenware chalice, he swallowed a capsule of psilocybin, an ingredient found in hallucinogenic mushrooms. Psilocybin has been illegal in the United States for more than 40 years. But Mr. Mihai, who had just finished treatment for Stage 3 Hodgkin’s lymphoma, was participating in a study looking at whether the drug can reduce anxiety and depression in cancer patients. More »
|